Latest SHENYANG Stories
SHENYANG, China, Feb.
-- PEG-Irinotecan is a novel, long-acting polymer-drug conjugate which inhibits Topo-I associated with solid tumors SHENYANG, China, Sept.
Leukotuximab is a novel, first-in-class Leukemia-specific mAb targeting JL-1 SHENYANG, China, Aug.
BEIJING, July 21, 2014 /PRNewswire-FirstCall/ -- Hollysys Automation Technologies, Ltd.
DUBLIN, March 13, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/q25vql/china) have announced the addition of the "China Non-standard
- Large; stout; burly.